Achieve Life Sciences (STU:SP4P) Total Liabilities : €18.93 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Achieve Life Sciences Total Liabilities?

Achieve Life Sciences's Total Liabilities for the quarter that ended in Mar. 2024 was €18.93 Mil.

Achieve Life Sciences's quarterly Total Liabilities increased from Sep. 2023 (€19.02 Mil) to Dec. 2023 (€19.09 Mil) but then declined from Dec. 2023 (€19.09 Mil) to Mar. 2024 (€18.93 Mil).

Achieve Life Sciences's annual Total Liabilities increased from Dec. 2021 (€17.23 Mil) to Dec. 2022 (€20.46 Mil) but then declined from Dec. 2022 (€20.46 Mil) to Dec. 2023 (€19.09 Mil).

Achieve Life Sciences Total Liabilities Historical Data

The historical data trend for Achieve Life Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achieve Life Sciences Total Liabilities Chart

Achieve Life Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

2.73

2.48

17.23

20.46

19.09

Achieve Life Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															19.01	17.74	19.02	19.09	18.93

Achieve Life Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Achieve Life Sciences's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	19.086	+	(0.006	+	-0.00099999999999744
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	19.09

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	17.763	-	-1.328
	=	19.09

Achieve Life Sciences's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	18.927	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	18.93

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	64.427	-	45.5
	=	18.93

Achieve Life Sciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Achieve Life Sciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Achieve Life Sciences (STU:SP4P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achieve Life Sciences Inc (STU:SP4P) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

ACHV:USA SP4P:Germany

Address

22722 29th Dr. SE, Suite 1000, Bothell, WA, USA, 98021

Website

https://www.achievelifesciences.com

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for nicotine addiction.

Achieve Life Sciences (STU:SP4P) Headlines

No Headlines